For the year ending 2025-12-31, CODX has $24,742,585 in assets. $4,113,921 in debts. $11,884,607 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 11,884,607 | |||
| Accounts receivable, net | 190,375 | |||
| Inventory, net | 992,397 | |||
| Income taxes receivable | 44,559 | |||
| Prepaid expenses and other current assets | 581,527 | |||
| Total current assets | 13,693,465 | |||
| Property and equipment, net | 2,272,098 | |||
| Operating lease right-of-use asset | 1,207,453 | |||
| Intangible assets, net | 7,219,000 | |||
| Investment in joint ventures | 350,569 | |||
| Total assets | 24,742,585 | |||
| Accounts payable | 1,878,225 | |||
| Accrued expenses | 865,301 | |||
| Operating lease liability, current | 662,258 | |||
| Contingent consideration liabilities, current | 119,036 | |||
| Deferred revenue | 14,800 | |||
| Total current liabilities | 3,539,620 | |||
| Operating lease liability | 574,301 | |||
| Total long-term liabilities | 574,301 | |||
| Total liabilities | 4,113,921 | |||
| Common stock, 0.001 par value 100,000,000 shares authorized 2,256,654 shares issued and 2,095,031 shares outstanding as of december 31, 2025 and 1,263,408 shares issued and 1,101,785 shares outstanding as of december 31, 2024 | 67,700 | |||
| Treasury stock, at cost 161,623 shares held as of december 31, 2025 and december 31, 2024, respectively | 15,575,795 | |||
| Additional paid-in capital | 116,510,298 | |||
| Accumulated deficit | -80,373,539 | |||
| Total stockholders equity | 20,628,664 | |||
| Total liabilities and stockholders equity | 24,742,585 | |||
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)